过敏治疗市场、过敏治疗市场规模、过敏治疗市场份额、过敏治疗市场预测、过敏治疗市场增长、过敏治疗市场分析市场增长、规模、市场份额、趋势、关键参与者分析和预测至 7.8% 的复合年增长率

  • Report Code : TIPRE00004584
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Allergy Treatment Market Size, Share, and CAGR by 2031

Buy Now

过敏治疗市场规模预计将从 2023 年的 202 亿美元增至 2031 年的 335 亿美元。预计 2023-2031 年市场复合年增长率为 7.8%。不断增加的研发 (R&D) 活动可能仍然是市场的主要趋势。

过敏治疗市场分析

不断增加的过敏治疗研发活动以开发创新药物可能仍将成为未来几年的新市场趋势。尽管市场上有多种过敏药物,但仍有许多呼吸道过敏和哮喘患者没有得到充分控制或对症治疗不足。例如,几种呼吸道过敏有患哮喘的风险。因此,几家顶级制造商正在设计针对过敏的临床试验方案。 HAL Allergy BV 针对呼吸道过敏的临床试验“过敏原免疫疗法”就是一个例子。因此,不断增加的研发活动将导致新型抗过敏药物的开发将在2021-2031年期间占据可观的市场增长。

过敏治疗市场概述

根据哮喘过敏诊所报告,世界过敏组织(WAO)公布的新数据显示,14%的人患有哮喘,其中20%患有过敏性鼻炎(AR),导致IgE介导的鼻粘膜炎症。目前,印度约有20-30%的人患有一种或多种过敏性疾病,且未来几年患病率还将上升。因此,过敏病例的增加将在未来十年加速抗过敏药物的需求。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

过敏治疗市场:

过敏治疗市场
  • Allergy Treatment Market
    年均复合增长率(2023 - 2031)
    7.8%
  • 2023 年市场规模
    202 亿美元
  • 2031 年市场规模
    335 亿美元

市场动态

增长动力
  • 过敏病例增加,抗过敏药物需求加速,市场利好
未来的趋势
  • 不断增加的研发 (R&D) 活动可能仍然是市场的主要趋势
机会
  • 过敏治疗新药的批准提供了利润丰厚的市场机会

关键人物;主力;重要一员

  • 强生服务公司
  • 赛诺菲
  • 艾伯维公司(艾尔建公司), Inc. (Allergan plc)
  • 辉瑞公司
  • 莱蒂制药公司
  • ALK-阿贝洛公司
  • 过敏治疗
  • 斯塔尔根·格里尔
  • 葛兰素史克
  • 德玛控股

区域概况

Allergy Treatment Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Allergy Treatment Market过敏类型
  • 眼睛过敏
  • 鼻炎
  • 哮喘
  • 皮肤过敏
  • 食物过敏
Allergy Treatment Market治疗
  • 抗过敏药
  • 免疫疗法
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

过敏治疗市场驱动因素和机遇

过敏病例增加,抗过敏药物需求加速,市场利好

根据美国儿科学会的报告,最常见的过敏类型是花粉热(过敏性鼻炎),这导致治疗费用高昂。例如,每年用于过敏治疗的直接和间接费用超过70亿美元。因此,良好的过敏治疗取决于病史、过敏测试结果以及症状的轻微或严重。此外,免疫疗法对于一些过敏患者来说是一种有效的治疗选择。有两种常见的免疫疗法。这些包括过敏注射和舌下免疫疗法(SLIT)。过敏注射包括注射过敏原;随着时间的推移逐渐增加剂量。此外,该人对过敏原的敏感度逐渐降低,因为这些疫苗对于一些对花粉、宠物、灰尘、蜜蜂和其他螫刺昆虫过敏以及哮喘的人来说效果很好。因此,过敏病例的增加加速了对抗过敏药物的需求,成为全球过敏治疗市场份额的主要驱动力。

过敏治疗新药的批准提供了利润丰厚的市场机会

治疗过敏的新药获批将为过敏治疗市场提供利润丰厚的市场机会。 2020年6月,卡迪拉制药有限公司宣布推出“比拉斯汀糖浆(30毫升)”和20毫克剂量的比拉斯汀片剂。此外,2022 年 3 月,Perrigo Company plc 宣布获得美国 FDA 的最终批准,可在非处方药 (OTC) 中使用“Nasonex® 24HR Allergy(糠酸莫米松一水合物 50mcg)”。此次批准标志着该公司“Nasonex”首次进入 OTC 市场。

过敏治疗市场报告细分分析

有助于推导过敏治疗市场分析的关键部分是类型、原因、疾病类型、类别和最终用户。

  • 根据过敏类型,过敏治疗市场分为眼过敏、鼻炎、哮喘、皮肤过敏、食物过敏等。 2023 年,鼻炎细分市场将占据更大的市场份额。
  • 按治疗方法,市场分为抗过敏药物和免疫疗法。 2023年,抗过敏药物领域占据最大市场份额。

按地区划分的过敏治疗市场份额分析

过敏治疗市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲以及南美洲和中美洲。

北美市场占据主导地位。在北美地区,美国占据过敏治疗市场最大份额。该地区顶级制造商的存在及其具有有效药理活性的创新抗过敏药物是促成市场主导地位的因素。预计亚太地区未来几年将以最高的复合年增长率增长。

过敏治疗市场报告范围

报告属性细节
2023年市场规模202亿美元
2031 年市场规模335亿美元
全球复合年增长率(2023 - 2031)7.8%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按过敏类型
  • 眼睛过敏
  • 鼻炎
  • 哮喘
  • 皮肤过敏
  • 食物过敏
按治疗
  • 抗过敏药
  • 免疫疗法
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 强生服务公司
  • 赛诺菲
  • 艾伯维公司(艾尔建公司)
  • 辉瑞公司
  • 莱蒂制药公司
  • ALK-阿贝洛公司
  • 过敏治疗
  • 斯塔尔根·格里尔
  • 葛兰素史克
  • 德玛控股
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

过敏治疗市场新闻和最新动态

过敏治疗市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。下面列出了过敏治疗市场的一些发展:

  • 2024年2月,诺华宣布美国食品药品监督管理局(USFDA)批准“Xolair(omalizumab)”。新推出的产品用于减少过敏反应,包括因 IgE 介导的食物过敏的成人和 1 岁及以上儿童患者意外接触一种或多种食物而发生的过敏反应。 (来源:诺华公司网站,2024 年 2 月)

过敏治疗市场报告的范围和可交付成果

《过敏治疗市场规模和预测(2021-2031)》报告对以下领域的市场进行了详细分析:

  • 过敏治疗市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
  • 过敏治疗市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 过敏治疗市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及过敏治疗市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the allergy treatment market in 2023?

North America region dominated the allergy treatment market in 2023.

What are the driving factors impacting the allergy treatment market?

Rising allergy cases accelerate demand for anti-allergic drugs to favor market is one of the most influential factors responsible for market growth.

What are the future trends of the allergy treatment market?

Rising Research & Development (R&D) activities to remain as a key trend for allergy treatment market.

Which are the leading players operating in the allergy treatment market?

Johnson and Johnson Services, Inc., Sanofi, AbbVie, Inc. (Allergan plc), Pfizer, Inc., LETIPharma, ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, GSK, and Dermapharm Holdings are the key players in the allergy treatment market.

What would be the estimated value of the allergy treatment market by 2031?

The estimated value of allergy treatment market accounted US$ 33.5 billion in 2031.

What is the expected CAGR of the allergy treatment market?

The CAGR for allergy treatment accounted 7.8% during 2023-2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..